Duchesnay, PeriPharm urge policy updates for women's health

Duchesnay and PeriPharm are emphasizing the critical need to update regulatory and reimbursement policies to improve access to innovations in women's health. They highlight that current frameworks may hinder the availability of new treatments and solutions for women. Advocating for policy reform, the companies aim to ensure that advancements in women's healthcare reach patients more effectively. This call to action addresses systemic barriers and seeks to foster a more supportive environment for women's health innovation.